Guidelines: Finnish Medical Association Duodecim Guidelines (Finland): Difference between revisions
From Beacon
m (Update categories.) |
No edit summary |
||
| Line 1: | Line 1: | ||
<span style="display:none">forproviders</span> <span style="display:none">forpolicymakers</span> | <span style="display:none">forproviders</span> <span style="display:none">forpolicymakers</span> <span style="display:none">finlandcountry</span> | ||
Go back to [[Finland]] page | Go back to [[Finland]] page | ||
Revision as of 20:38, 2 December 2025
Go back to Finland page
Primary purpose: To provide independent national treatment recommendations based on research evidence.
Sponsor, manager or home institution: Duodecim of the Finnish Medical Society and other institutions.
Type of information: Treatment recommendations; Epidemiology and etiology; Prevalence classification and histological classification; Diagnostics; Monitoring; quality of life of patients of prostate, lung, oral cancer and palliative care and hospice care recommendations. Click here to learn more.
Cancer areas of interest: C00-C97: All cancer types. Click here to learn more.
Access to information: Click here to access.